The 340B drug discount program is under scrutiny yet again. This time the GAO is calling for additional oversight of the program and its contracted pharmacies with a report that shows nearly half of covered entities didn’t pass drug discounts to low-income patients.
GAO: 340B hospitals, outside pharmacies need more oversight
